Cargando…

Disopyramide for Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy (HCM) is a cardiac disease characterized by hypertrophy of a nondilated left ventricle without any other cardiac or systemic disease that could account for observed hypertrophy. We present a female patient with the diagnosis of obstructive HCM, which is rare because sudde...

Descripción completa

Detalles Bibliográficos
Autores principales: Sanchez-Nadales, Alejandro, Anampa-Guzmán, Andrea, Khan, Amir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6592455/
https://www.ncbi.nlm.nih.gov/pubmed/31263635
http://dx.doi.org/10.7759/cureus.4526
_version_ 1783429885076701184
author Sanchez-Nadales, Alejandro
Anampa-Guzmán, Andrea
Khan, Amir
author_facet Sanchez-Nadales, Alejandro
Anampa-Guzmán, Andrea
Khan, Amir
author_sort Sanchez-Nadales, Alejandro
collection PubMed
description Hypertrophic cardiomyopathy (HCM) is a cardiac disease characterized by hypertrophy of a nondilated left ventricle without any other cardiac or systemic disease that could account for observed hypertrophy. We present a female patient with the diagnosis of obstructive HCM, which is rare because sudden death is frequently the first clinical presentation. Her symptoms were resistant to medical treatment and the patient did not want invasive procedures. Disopyramide was added, and it improved her symptoms. Disopyramide is a safe and effective medication that reduces symptoms and delays the need for invasive therapy. Disopyramide was added to the treatment of the patient and it improved her symptoms.
format Online
Article
Text
id pubmed-6592455
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-65924552019-07-01 Disopyramide for Hypertrophic Cardiomyopathy Sanchez-Nadales, Alejandro Anampa-Guzmán, Andrea Khan, Amir Cureus Cardiac/Thoracic/Vascular Surgery Hypertrophic cardiomyopathy (HCM) is a cardiac disease characterized by hypertrophy of a nondilated left ventricle without any other cardiac or systemic disease that could account for observed hypertrophy. We present a female patient with the diagnosis of obstructive HCM, which is rare because sudden death is frequently the first clinical presentation. Her symptoms were resistant to medical treatment and the patient did not want invasive procedures. Disopyramide was added, and it improved her symptoms. Disopyramide is a safe and effective medication that reduces symptoms and delays the need for invasive therapy. Disopyramide was added to the treatment of the patient and it improved her symptoms. Cureus 2019-04-23 /pmc/articles/PMC6592455/ /pubmed/31263635 http://dx.doi.org/10.7759/cureus.4526 Text en Copyright © 2019, Sanchez-Nadales et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Cardiac/Thoracic/Vascular Surgery
Sanchez-Nadales, Alejandro
Anampa-Guzmán, Andrea
Khan, Amir
Disopyramide for Hypertrophic Cardiomyopathy
title Disopyramide for Hypertrophic Cardiomyopathy
title_full Disopyramide for Hypertrophic Cardiomyopathy
title_fullStr Disopyramide for Hypertrophic Cardiomyopathy
title_full_unstemmed Disopyramide for Hypertrophic Cardiomyopathy
title_short Disopyramide for Hypertrophic Cardiomyopathy
title_sort disopyramide for hypertrophic cardiomyopathy
topic Cardiac/Thoracic/Vascular Surgery
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6592455/
https://www.ncbi.nlm.nih.gov/pubmed/31263635
http://dx.doi.org/10.7759/cureus.4526
work_keys_str_mv AT sancheznadalesalejandro disopyramideforhypertrophiccardiomyopathy
AT anampaguzmanandrea disopyramideforhypertrophiccardiomyopathy
AT khanamir disopyramideforhypertrophiccardiomyopathy